Patents by Inventor Matthias Eckhardt

Matthias Eckhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040122228
    Abstract: The invention relates to new purine derivatives of general formula 1
    Type: Application
    Filed: August 4, 2003
    Publication date: June 24, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Roland Maier, Frank Himmelsbach, Matthias Eckhardt, Elke Langkopf, Michael Mark, Ralf R. H. Lotz
  • Publication number: 20040097510
    Abstract: The present invention relates to substituted xanthines of general formula 1
    Type: Application
    Filed: August 12, 2003
    Publication date: May 20, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf R.H. Lotz, Mohammad Tadayyon
  • Publication number: 20040087587
    Abstract: The present invention relates to substituted xanthines of general formula 1
    Type: Application
    Filed: October 24, 2003
    Publication date: May 6, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Frank Himmelsbach, Michael Mark, Matthias Eckhardt, Elke Langkopf, Roland Maier, Ralf Lotz
  • Publication number: 20040077645
    Abstract: The present invention relates to substituted xanthines of general formula 1
    Type: Application
    Filed: December 5, 2003
    Publication date: April 22, 2004
    Inventors: Frank Himmelsbach, Michael Mark, Matthias Eckhardt, Elke Langkopf, Roland Maier, Ralf R H Lotz
  • Patent number: 6645984
    Abstract: Compounds of the formula (I), are described in which X is halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylthio or (C1-C4)-alkylsulfinyl; R1 is halogen, (C1-C4)-haloalkyl, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy or cyano; m is 0 to 3; n is 1 to 5; Z is oxygen, sulfur, CH2 or NR2; R2 is CN, (C1-C4)-alkoxy-(C1-C4)-alkyl, CHO, (C1-C6)-alkylcarbonyl, (C1-C6)-alkoxycarbonyl or (CW)NR3R4; R3, R4 are H or (C1-C6)-alkyl; W is O or S; G is mono- to tetrasubstituted isoxazoline which is attached in the 3-, 4- or 5-position to the adjacent phenyl ring. The compounds are suitable for use as pesticides.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: November 11, 2003
    Assignee: Aventis CropScience GmbH
    Inventors: Ralf Braun, Oswald Ort, Karl-Josef Haack, Matthias Eckhardt, Waltraud Hempel, Maria-Theresia Thönessen
  • Publication number: 20030114501
    Abstract: Arylisoxazoline derivatives, processes for their preparation and their use as pesticides
    Type: Application
    Filed: March 22, 2002
    Publication date: June 19, 2003
    Inventors: Ralf Braun, Oswald Ort, Karl-Josef Haack, Matthias Eckhardt, Waltraud Hempel, Maria-Theresia Thonessen
  • Publication number: 20020198205
    Abstract: The present invention relates to substituted xanthines of general formula 1
    Type: Application
    Filed: February 22, 2002
    Publication date: December 26, 2002
    Inventors: Frank Himmelsbach, Michael Mark, Matthias Eckhardt, Elke Langkopf, Roland Maier, Ralf Lotz
  • Patent number: 6107299
    Abstract: Compounds of formula I, N-oxides or salts, thereof ##STR1## in which q is 0, 1 or 2A is CH and D is N.sup.+ R.times.1/n Q.sup.n- or A is N and D is N.sup.+ R.times.1/n Q.sup.n- or A is CH or N and D is Nor A is N.sup.+ R.times.1/n Q.sup.n- and D is N, R is CR.sup.6 R.sup.7 D.sup.a R.sup.8,Q.sup.n- is an inorganic or organic anion, n being 1, 2, 3 or 4;X is NH, O or S(O).sub.q, (q is 0, 1 or 2); and the R groups have various meanings as defined in the claims are useful pesticidal, especially insecticidal activity.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: August 22, 2000
    Assignee: Hoechst Schering AgrEvo GmbH
    Inventors: Harald Jakobi, Matthias Eckhardt, Wolfgang Schaper, Ralf Braun, Gerhard Krautstrunk, Oswald Ort, Ulrich Sanft, Maria-Theresia Thonessen, Werner Bonin
  • Patent number: 6020201
    Abstract: A protein having polysialyl transferase activity, which a) is a product of a prokaryotic or eukaryotic expression of an exogenous DNA, b) is coded by the DNA sequence shown in SEQ ID No. 1, c) is coded by the DNA sequences which hybridize with the sequences SEQ ID No. 1 and/or SEQ ID No. 3, d) is coded by DNA sequences which if there was no degeneracy of the genetic code, would hybridize with the sequences defined in b) to c), and e) catalyzes the polycondensation of .alpha.-2,8-linked sialic acids, and its related nucleic acid molecules and fragments are useful for the production of therapeutic agents for tumor therapy.
    Type: Grant
    Filed: July 24, 1997
    Date of Patent: February 1, 2000
    Assignee: Boehringer Mannheim GmbH
    Inventors: Rita Gerardy-Schahn, Minoru Fukuda, Jun Nakayama, Matthias Eckhardt
  • Patent number: 5959078
    Abstract: Isolated nucleic acid molecules encoding polysialyl transferases, and the polysialyl transferases themselves are disclosed. SEQ ID NOS: 1, 2, 7 and 8 present examples of these. The nucleic acid molecules and the proteins can be used diagnostically or therapeutically. Additionally, antisense oligonucleotides and antibodies are described, which can also be used diagnostically or therapeutically.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: September 28, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventors: Rita Gerardy-Schahn, Minoru Fukuda, Jun Nakayama, Matthias Eckhardt
  • Patent number: 5849904
    Abstract: Isolated nucleic acid molecules encoding polysialyl transferases, and the polysialyl transferases themselves are disclosed. SEQ ID NOS: 1, 2, 7 and 8 present examples of these. The nucleic acid molecules and the proteins can be used diagnostically or therapeutically. Additionally, antisense oligonucleotides and antibodies are described, which can also be used diagnostically or therapeutically.
    Type: Grant
    Filed: December 21, 1995
    Date of Patent: December 15, 1998
    Assignees: Boehringer Mannheim GmbH, La Jolla Cancer Research Foun.
    Inventors: Rita Gerardy-Schahn, Minoru Fukuda, Jun Nakayama, Matthias Eckhardt
  • Patent number: 5747326
    Abstract: Isolated nucleic acid molecules encoding polysialyl transferases, and the polysialyl transferases themselves are disclosed. SEQ ID NOS: 1, 2, 7 and 8 present examples of these. The nucleic acid molecules and the proteins can be used diagnostically or therapeutically. Additionally, antisense oligonucleotides and antibodies are described, which can also be used diagnostically or therapeutically.
    Type: Grant
    Filed: July 17, 1995
    Date of Patent: May 5, 1998
    Assignees: La Jolla Cancer Research Foundation, Boehringer Mannheim GmbH
    Inventors: Rita Gerardy-Schahn, Minoru Fukuda, Jun Nakayama, Matthias Eckhardt